<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04758156</url>
  </required_header>
  <id_info>
    <org_study_id>1905-1831</org_study_id>
    <nct_id>NCT04758156</nct_id>
  </id_info>
  <brief_title>Comparison Between a 1L of Polyethylene Glycol+Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy</brief_title>
  <official_title>Comparison Between a 1L of Polyethylene Glycol+Ascorbic Acid as a Split Dose Bowel Preparation for Colonoscopy: Prospective, Randomized, Parallel, Multi-center Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Comparison between a 1L of polyethylene glycol+ascorbic acid as a split dose and oral sulfate&#xD;
      solution bowel preparation for colonoscopy&#xD;
&#xD;
      study design: prospective, randomized, parallel, multi-center trial in 3 hospitals in Korea (&#xD;
      Seoul National University hospital, Seoul National University Bundang hospital, Seoul&#xD;
      Metropolitan Government-Seoul National University )&#xD;
&#xD;
      patient inclusion criteria&#xD;
&#xD;
      - aged 20-75 adults (out-clinic patients) scheduled for colonoscopy for any indication within&#xD;
      the normal process of care&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2021</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Boston Bowel Preparation Scale (BBPS)</measure>
    <time_frame>at the time of colonoscopy procedure</time_frame>
    <description>Bowel cleansing score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>questionnaire gathered for Tolerability, compliance, satisfaction</measure>
    <time_frame>on the 1 day of colonoscopy via questionnaire</time_frame>
    <description>information gathered via questionnaire</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Colon Adenoma</condition>
  <condition>Colonic Polyp</condition>
  <arm_group>
    <arm_group_label>CleanViewAL</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>1L polyethylene glycol+ascorbic acid split dose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SUPREP</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral sulfate solutiom</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CleanViewAL</intervention_name>
    <description>1L PEG + ascorbic acid bowel preparation for colonoscopy</description>
    <arm_group_label>CleanViewAL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>SUPREP</intervention_name>
    <description>Oral sulfate solution for colonoscopy bowel preparation</description>
    <arm_group_label>SUPREP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult out clinic patients scheduled for colonoscopy for any indication within the&#xD;
             normal process of care&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  previous history of significant gastrointestinal surgeries (except for appendectomy)&#xD;
&#xD;
          -  known or clinically suspicious Inflammatory bowel disease patients&#xD;
&#xD;
          -  known or suspected ileus/ GI obstruction&#xD;
&#xD;
          -  previous history of major cancer or currently on treating cancer&#xD;
&#xD;
          -  Major cardiovascular disease, respiratory disease, liver, hematologic diseases with&#xD;
             complication&#xD;
&#xD;
          -  severe cognitive impairment / dementia / confusion state&#xD;
&#xD;
          -  past history within the last 12 months or current episode of severe constipation&#xD;
             severe constipation&#xD;
&#xD;
          -  Regular use of laxatives or colon motility-altering drugs (i. e. more than 2 - 3 times&#xD;
             per week) in the last 28 days prior to screening and/or laxative use within 72 hours&#xD;
             prior to administration of the preparation)&#xD;
&#xD;
          -  women who are pregnant or lactating&#xD;
&#xD;
          -  known phenylketonuria, glucose-6-phosphate dehydrogenase deficiency&#xD;
&#xD;
          -  those who were allergic to any preparation components.&#xD;
&#xD;
          -  those who, in the opinion of the investigator, should not be included in the study for&#xD;
             any reason&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jong Pil Im, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hyun Jung Lee, MD, PhD</last_name>
    <phone>+82-2-740-3439</phone>
    <email>guswjd80@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul national university hospital</name>
      <address>
        <city>Seoul</city>
        <zip>03080</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hyun Jung Lee, MD, PhD</last_name>
      <phone>+82-2-740-3439</phone>
      <email>guswjd80@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>February 15, 2021</study_first_submitted>
  <study_first_submitted_qc>February 16, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2021</study_first_posted>
  <last_update_submitted>July 4, 2021</last_update_submitted>
  <last_update_submitted_qc>July 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Hyun Jung Lee</investigator_full_name>
    <investigator_title>Assistant Professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenoma</mesh_term>
    <mesh_term>Colonic Polyps</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

